Table 2. Clinicopathologic characteristics of the patients.
Disease | Histology | Training set (n = 268) | Validation set (n = 156) | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Patients | FIGO (No. of patients) | Age (years) | No. of Patients | FIGO (No. of patients) | Age (years) | ||||||||||||||
I | II | III | IV | unknown | Range | Median | Mean | I | II | III | IV | unknown | Range | Median | Mean | ||||
Ovarian disease | 230 | 93 | |||||||||||||||||
Benign tumor | 114 | 22–81 | 44.5 | 47.5 | 40 | 20–76 | 42.5 | 42.8 | |||||||||||
EMS | 71 | 28–71 | 43 | 44.2 | 17 | 23–57 | 44 | 41.4 | |||||||||||
non-EMS | 43 | 22–81 | 54 | 52.9 | 23 | 20–76 | 41 | 43.9 | |||||||||||
Borderline tumor | 8 | 8 | 0 | 0 | 0 | 0 | 31–75 | 53 | 55.8 | 15 | 14 | 0 | 1 | 0 | 0 | 16–80 | 46 | 47.6 | |
Ovarian cancer | 108 | 38 | |||||||||||||||||
CCC-subtype | 29 | 15 | 3 | 8 | 3 | 0 | 37–79 | 57 | 56.7 | 7 | 3 | 1 | 3 | 0 | 0 | 38–71 | 58 | 57.7 | |
non-CCC-subtypes | 79 | 22 | 12 | 25 | 16 | 4 | 15–84 | 57 | 55.0 | 31 | 8 | 4 | 11 | 6 | 2 | 27–84 | 63 | 61.5 | |
Serous | 27 | 3 | 2 | 14 | 8 | 0 | 15–79 | 58 | 55.2 | 17 | 3 | 2 | 9 | 2 | 1 | 36–76 | 65 | 63.3 | |
Endometrioid | 28 | 11 | 8 | 6 | 1 | 2 | 35–84 | 55 | 56.6 | 4 | 0 | 2 | 1 | 1 | 0 | 61–77 | 65 | 67.0 | |
Mucinous | 8 | 5 | 1 | 0 | 2 | 0 | 24–77 | 47.5 | 47.1 | 4 | 3 | 0 | 0 | 1 | 0 | 27–75 | 46.5 | 48.8 | |
Other | 16 | 3 | 1 | 5 | 5 | 2 | 25–75 | 60 | 56.8 | 6 | 2 | 0 | 1 | 2 | 1 | 37–84 | 62 | 61.2 | |
Uterine disease | 38 | 28–88 | 47 | 49.8 | 58 | 26–85 | 47 | 50.7 | |||||||||||
Uterine fibroids | 5 | 35–70 | 40 | 44.8 | 17 | 28–66 | 46 | 46.2 | |||||||||||
Cervical cancer | 18 | 7 | 7 | 0 | 1 | 3 | 28–65 | 40 | 42.8 | 15 | 11 | 3 | 0 | 0 | 1 | 26–70 | 46 | 47.6 | |
Endometrial cancer | 15 | 8 | 2 | 1 | 4 | 0 | 35–88 | 60 | 51.4 | 26 | 15 | 2 | 6 | 1 | 2 | 38–85 | 53 | 55.7 | |
Other disease | 0 | 5 | 33–66 | 60 | 55.4 | ||||||||||||||
Total | 268 | 156 |
Abbreviations: EMS, endometriosis.